IPAD-DB ID | C01262 |
Name | Gallic Acid |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 7 H 6 O 5 |
Molecular Weight | 170.12 g/mol |
IUPAC Name | 3, 4, 5-trihydroxybenzoic acid |
InChI | InChI=1S/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2, 8-10H, (H, 11, 12) |
InChIKey | LNTHITQWFMADLM-UHFFFAOYSA-N |
Canonical SMILES | C1=C(C=C(C(=C1O)O)O)C(=O)O |
PubChem CID | 370 |
DrugBank Accession Number | - |
CAS Registry Number | 149-91-7 |
Molecular Weight(Computed by SwissADME) | 170.12 |
Hac(Computed by SwissADME) | 12 |
Volume(Computed by ADMETlab 2.0) | 154.477 |
Density(Computed by ADMETlab 2.0) | 1.101 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 7 |
Flexibility(Computed by ADMETlab 2.0) | 0.143 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -1.22 |
LogD(Computed by ADMETlab 2.0) | 0.343 |
logP(Computed by ADMETlab 2.0) | 0.5 |
TPSA(Computed by SwissADME) | 97.99 Ų |
Hbond Acceptor(Computed by SwissADME) | 5 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 1 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -7.75 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | No, 2 violations: MR<40, #atoms<20 |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | No, 1 violation: MW<200 |
Bioavailability Score(Computed by SwissADME) | 0.56 |